Please let others know who might be interested in this article. Thanks!
Half-life of two minutes makes it really difficult to be useful...
If this turns out to be true, it is a great discovery.
It’s a huge industry killer. Just imagine if they could end type II with a single weekly pill that not only lowers your blood sugar, but reduces your weight and makes you healthier?
I hope these scientists don’t find themselves on a dissapearing 777.
Interesting development.... worth keeping an eye on
Patient compliance would be astronomically high.
This article is a joke. GLP-1 (glucagon like polpypetide 1) was discovered about 25 years ago. It lowers blood sugar and the human gut secretes it naturally, but it has a short half-life, because it is inactivated by DPP4 (dipeptidyl peptidase 4), another naturally occurring enzyme in the human body. Januvia (by Merck) was the first DPP-4 inhibitor, used to block the DPP-4 enzyme’s degradation of GLP-1, thus lowering blood sugar. Next came a natural mimetic (copy) of GLP-1, Byetta, and it’s analog (synthetic) twin Bydureon, both owned by Astra Zeneca. These drugs came out in the mid 2000’s. Another GLP-1 analog, Victoza (from Novo Nordisk) came out in 2010. There are also a host of Januvia copies on the market (saxagliptin, alogliptin, linogliptin,etc.). Before you start thinking this is a new breakthrough, educate yourselves on the diabetes therapies.